Study Configuration

Durham, North Carolina, U.S., September 24, 2026 Clywedog Therapeutics has announced final results from its Phase 1b clinical study...

Pleasanton, California, U.S., September 24, 2026 Veeva Systems Inc. has announced the Veeva Study Builder Agent, a new artificial...